• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

EXACT Therapeutics

Less than 1K followers

EXTX

Euronext Growth Oslo

Biotechnology & Pharmaceuticals

Health Care

Overview
Investor consensus

EXACT Therapeutics operates in the medical technology sector. The company specializes in the development of medical devices. The product portfolio is broad and includes, for example, technical platforms for drug testing. In addition to the main business, related ancillary services and value-added products are also offered. The business is operated globally with the largest presence in the Nordic market. The company was previously known as Phoenix Solutions and is headquartered in Oslo.

Read more
Market cap
-
Turnover
-
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
3.9
2026

Interim report Q2'26

All
Press releases
ShowingAll content types

Regulatory press release6/17/2026, 1:31 PM

EXTX: Received application for delisting

EXACT Therapeutics
Regulatory press release6/4/2026, 7:00 AM

EXACT Therapeutics - webcast presentation

EXACT Therapeutics
Regulatory press release6/1/2026, 3:05 PM

EXACT Therapeutics: Announces webcast regarding strategic intent to delist the company's shares from listing on Euronext Growth, Oslo

EXACT Therapeutics

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/29/2026, 7:09 AM

EXACT Therapeutics - Notice for Annual General Meeting 2026

EXACT Therapeutics
Regulatory press release5/29/2026, 7:09 AM

EXACT Therapeutics: Strategic intent to delist the company's shares from listing on Euronext Growth, Oslo

EXACT Therapeutics
Regulatory press release4/9/2026, 5:14 AM

EXACT Therapeutics - Annual Report 2025

EXACT Therapeutics
Regulatory press release3/26/2026, 11:00 AM

EXACT Therapeutics AS: Share capital increase registered

EXACT Therapeutics
Regulatory press release3/13/2026, 3:28 PM

EXACT Therapeutics AS - Minutes from extraordinary general meeting on 13 March 2026

EXACT Therapeutics
Regulatory press release3/3/2026, 1:15 PM

EXACT Therapeutics - First patient dosed in Europe in Phase 2 trial in patients with locally advanced pancreatic cancer

EXACT Therapeutics
Regulatory press release2/27/2026, 12:16 PM

EXACT Therapeutics AS: Notice of extraordinary general meeting

EXACT Therapeutics
Regulatory press release2/27/2026, 7:54 AM

EXACT Therapeutics AS: Warrants exercise

EXACT Therapeutics
Regulatory press release2/12/2026, 9:48 AM

EXTX: Financial calendar

EXACT Therapeutics
Regulatory press release2/11/2026, 7:00 AM

EXACT Therapeutics: Investor presentation for the global investor call regarding the ongoing warrants exercise program

EXACT Therapeutics
Regulatory press release2/6/2026, 7:30 AM

EXACT Therapeutics: Global investor call regarding the ongoing warrants exercise program

EXACT Therapeutics
Regulatory press release2/5/2026, 12:19 PM

EXACT Therapeutics: Correction of final warrants exercise date

EXACT Therapeutics
Regulatory press release2/5/2026, 8:17 AM

EXACT Therapeutics: Warrants exercise by leading shareholders and primary insiders

EXACT Therapeutics
Regulatory press release2/5/2026, 7:30 AM

EXACT Therapeutics: Exercise of Warrants by GE Medical Holding AB

EXACT Therapeutics
Regulatory press release1/27/2026, 7:00 AM

EXACT Therapeutics: Positive initial safety read-out from the Phase 2 ENACT trial in pancreatic cancer, triggering option to exercise warrants

EXACT Therapeutics
Regulatory press release1/8/2026, 7:30 AM

EXTX: EXACT Therapeutics' Phase 2 trial in pancreatic cancer patients to be presented at the 2026 ASCO Gastrointestinal Cancers Symposium

EXACT Therapeutics
Regulatory press release11/25/2025, 11:57 AM

EXTX: EXACT Therapeutics to present company update

EXACT Therapeutics